Baricitinib retention rate: ‘real-life’ data from a mono-centric cohort of patients affected by rheumatoid arthritis

Baricitinib retention rate: ‘real-life’ data from a mono-centric cohort of patients affected by rheumatoid arthritis

ObjectivesThe aim of this retrospective study was to evaluate baricitinib retention rate in patients affected by rheumatoid arthritis. Secondary aims were to compare the impact on treatment persistence of monotherapy and other variables such as systemic corticosteroid use, line of treatment, disease...

Full description

Bibliographic Details
Main Authors: Caterina Baldi, Virginia Berlengiero, Paolo Falsetti, Alessandra Cartocci, Edoardo Conticini, Roberto D’Alessandro, Emilio D’Ignazio, Marco Bardelli, Marta Fabbroni, Luca Cantarini, Bruno Frediani, Stefano Gentileschi
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Medicine
Subjects:
rheumatoid arthritis
baricitinib
retention rate
treatment
real-life
JAK inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1176613/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1176613/full

Similar Items